Text Size Text Size - Small Text Size - Medium Text Size - Large
SITE MAP   |   GLOSSARY
Stavzor

About STAVZOR

STAVZOR (valproic acid) small, easy-to-swallow soft gel capsules are an innovative valproate formulation formulated to help your patients start — and stay on — their therapy.

STAVZOR easy-to-swallow soft gel capsules are up to 40% smaller than Depakote® or Depakote ER®* tablets (500 mg dosage formulation). In addition, STAVZOR enteric properties allow the valproate to be absorbed in the small intestine.

STAVZOR is indicated for:

  • the acute treatment of manic episodes associated with bipolar disorder
  • monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures
  • prophylaxis of migraine headaches

Learn more:

*Depakote/Depakote ER (divalproex sodium) are registered trademarks of Abbott Laboratories, North Chicago, IL.

Request Samples